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Complex polyketides are characterized by multiple
chiral centers harboring hydroxyl and alkyl substitu-
ents. To investigate the mechanisms by which these
stereocenters are set, several high-resolution struc-
tures of the ketoreductase (KR) domain from the
second module of the amphotericin modular polyke-
tide synthase (PKS) were solved. This first structural
analysis of an A-type KR helps reveal how these
KRs direct polyketide intermediates into their active
sites from the side opposite that used by B-type
KRs, resulting in a b-hydroxyl group of opposite
stereochemistry. A comparison of structures ob-
tained in the absence and presence of ligands
reveals an induced fit mechanism that is important
for catalysis. Activity assays of mutants of KRs
from the first and second modules of the amphoteri-
cin PKS reveal the relative contributions of several
active site residues toward catalysis and stereo-
control. Together, these results highlight the possi-
bility of region-specific modification of polyketides
through active site engineering of KRs.
INTRODUCTION
Modular polyketide synthases (PKSs) are large biosynthetic
assembly lines responsible for the synthesis of structurally
diverse and clinically important polyketide natural products
(Khosla et al., 2007, 2009; Meier and Burkart, 2009). Each
module within a PKS usually carries out one round of chain
elongation and b-keto processing, resulting in a colinearity
between the series of modules and the chemical structure of
the resultant products. A minimal module has three domains:
a ketosynthase (KS) that accepts a growing polyketide chain
from an upstream module and catalyzes its condensation to an
extender unit; an acyltransferase (AT) that selects the extender
unit (e.g., methylmalonate, malonate) to be added; and an
acyl carrier protein (ACP) that shuttles the growing polyketide
intermediate via an 18 A˚ phosphopantetheinyl arm between
enzymatic domains. Most modules possess one or moreStructure 18, 91b-carbon-processing enzymes. Ketoreductases (KRs) reduce
b-keto groups to b-hydroxyl groups, dehydratases (DHs) remove
the b-hydroxyl group to form a double bond, and enoylreduc-
tases (ERs) further reduce the b-carbon to a methylene function-
ality. Compared with fatty acid synthases (FASs), which catalyze
all three reactions, PKSs may use all, some, or none of the
b-carbon processing activities.
Hydroxyl-bearing chiral centers are commonly introduced
into polyketide products by KRs. The first studies of PKS stereo-
control used intact modules (Holzbaur et al., 1999). Incubating
the first polypeptide of the 6-deoxyerythronolide B synthase
(DEBS1) with an N-acetyl cysteamine thioester (SNAC, where
‘‘S’’ indicates the thioester linkage) derivative of the natural unre-
duced diketide intermediate yielded the initial details about
stereocontrol in the first two KRs of the erythromycin PKS.
More recently, the expression of KR domains separated from
their native PKSs has made it possible to measure the kinetics
and stereochemistry of ketoreduction (Baerga-Ortiz et al.,
2006; O’Hare et al., 2006; Siskos et al., 2005). EryKR1 and
TylKR1 (named by their corresponding PKS and module of
origin) show very high stereospecificity toward substrate
analogs; however, other EryKRs give mixtures of all possible
stereoisomeric products. Since EryKR1, EryKR2, EryKR5, and
EryKR6 were each shown to utilize the 4-pro-S hydride of the
NADPH cofactor in their reduction reactions, differences in
resulting b-hydroxyl stereochemistry were hypothesized to arise
through alternate binding modes of polyketide substrates
(McPherson et al., 1998; Yin et al., 2001). Correlations were
discovered between KR sequence motifs and the stereochemis-
tries of the resulting hydroxyl groups: an LDD motif is present in
‘‘B-type’’ KRs that produce b-hydroxyl groups of ‘‘R’’ stereo-
chemistry and a tryptophan is present in ‘‘A-type’’ KRs that
produce b-hydroxyl groups of ‘‘S’’ stereochemistry (quotation
marks surround R and S according to a convention developed
for polyketides that sometimes deviates from the standard RS
system) (Caffrey, 2003; Reid et al., 2003; Keatinge-Clay, 2007).
The crystal structures of EryKR1 and TylKR1 have revealed
that the conserved catalytic residues of KRs cooperate as
observed in other short-chain dehydrogenase/reductase (SDR)
enzymes (Keatinge-Clay and Stroud, 2006; Keatinge-Clay,
2007). The b-carbonyl to be reduced is positioned adjacent to
the nicotinamide ring by a tyrosine and a serine so that the
4-pro-S hydride can attack the b-carbonyl. As anticipated, the
A- and B-type sequence motifs reside on opposite sides of3–922, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 913
Figure 1. AmpKR2 within the Amphotericin
PKS
(A) In the antifungal amphotericin B two stereo
centers are set by AmpKR2. Intermediates bound
to the loading module and first extender modules
of the amphotericin PKS modules are detailed.
(B) AmpKR2 catalyzes the reduction of (2R, 4S,
5S)-5-hydroxy-2,4-dimethyl-3-oxohexanoate holo-
AmpACP2 thioester to install a b-hydroxyl group
of ‘‘S’’ stereochemistry.
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Structure and Function of A-Type Ketoreductasesthe catalytic groove. The LDD motif is hypothesized to mediate
the entrance of the phosphopantetheinyl-bound b-ketoacyl
thioester substrate from the right side of the catalytic groove
(the side closer to the NADPH binding site), resulting in formation
of an ‘‘R’’-hydroxyl group, while the conserved tryptophan is
hypothesized to guide the substrate into the groove from the
left side, thereby presenting the opposite face of the b-keto
group to NADPH to produce an ‘‘S’’-hydroxyl group. Reconsti-
tuted PKS systems have now been developed to study KR
stereocontrol toward acyl-ACP substrates (Castonguay et al.,
2007, 2008; Valenzano et al., 2009). Through combining
KS+AT didomains and KR domains from different modules,
it was established that KRs are capable of controlling the stereo-
chemical outcome at both the hydroxyl- and alkyl-bearing chiral
centers.
Identifying the determinants of stereocontrol has been more
challenging for a-substituents than for b-hydroxyl groups. In vitro
studies with DEBS1 fused to a thioesterase (TE) revealed that
EryMod1 catalyzes an additional epimerization; however, the
timing of epimerization and whether EryKS1 or EryKR1 is the
responsible catalytic domain remained unclear (Weissman
et al., 1997). EryMod3 installs an epimerized methyl group on
C-8 of 6-deoxyerythronolide B (6-dEB). Experiments with iso-
lated KS+AT didomains and KR domains proved that EryKS3
does not mediate epimerizaton and suggested that the reduc-
tase-incompetent EryKR3 does(Castonguay et al., 2007).
Further incubation experiments with KR domains derived from
PKS modules that produce an epimerized methyl group
established that epimerization occurs after KS-catalyzed chain
elongation and is, in fact, catalyzed by KR domains (Valenzano
et al., 2009). A mechanism involving enolization of the
b-ketoacyl-ACP thioester and uncatalyzed tautomerization
back to the keto-form was proposed according to the structure
of EryKR1 (Keatinge-Clay and Stroud, 2006).
Although some successes in swapping KRs have been
reported, the scarcity of details surrounding KR substrate
specificity and stereocontrol has prevented major advances is
this area (Kellenberger et al., 2008). Site-directed engineering914 Structure 18, 913–922, August 11, 2010 ª2010 Elsevier Ltd All rights reservedof b-carbon-processing enzymes may
be a more promising route to obtaining
novel polyketides with potentially
improved bioactivities. Structures of
EryKR1 and TylKR1 have been solved;
however, both are B-type KRs that install
b-hydroxyl groups of ‘‘R’’ stereochem-
istry into the growing polyketide chain.
Here, we report the first structure of anA-type KR, AmpKR2, which catalyzes the formation of a
b-hydroxyl group of ‘‘S’’ stereochemistry at C-35 and a methyl
group of ‘‘R’’ stereochemistry at C-34 in the complex polyketide
amphotericin (Figure 1). The structure helps elucidate the
mechanisms by which A-type KRs determine the stereochem-
istry of b-hydroxyacyl-ACP products. The roles of key residues,
such as the signature A-type tryptophan, were investigated by
structural and functional studies of mutants, both of AmpKR2
and another A-type KR, AmpKR1. Stereocontrol of a-substituent
stereochemistry mediated by AmpKR2 was largely reversed
through a Q364H mutation. Induced fit conformational changes
of the lid helix and the preceding loop were observed in liganded
structures. The structural and functional studies of AmpKR2
presented here help set the stage for the rational engineering
of KRs in modular PKSs.
RESULTS
Crystallization of AmpKR2 Domain
Two recently solved KR structures from the first modules of the
erythromycin and tylosin PKSs have helped reveal the basis for
stereocontrol in PKSs at atomic resolution (Keatinge-Clay,
2007; Keatinge-Clay and Stroud, 2006). However, neither KR
mediates the formation of a b-hydroxyl group of ‘‘S’’ stereo-
chemistry. To detail the formation of such b-hydroxyl groups
in polyketide biosynthesis, we focused on AmpKR2, which
reduces the b-keto group of (2R, 4S, 5S)-5-hydroxyl-2,4-
dimethyl-3-oxohexanoate holo-AmpACP2 thioester to a b-
hydroxyl group of ‘‘S’’ stereochemistry (Figure 1B) (Caffrey
et al., 2001). The boundaries of AmpKR2 were chosen using a
sequence alignment with EryKR1 and TylKR1; D2529, which is
3 residues upstream of conserved (H/L/M/F/Y)XXXW sequence
motif, was selected as the N terminus, while E3003, which is 8
residues upstreamof ACP, was selected as the C terminus (Alek-
seyev et al., 2007). The corresponding DNA fragment was cloned
from Streptomyces nodosus genomic DNA and ligated into the
NdeI and EcoRI restriction sites of pET28b (Novagen). N-termi-
nally His6-tagged protein, purified to homogeneity, was entered
Table 1. Data Collection and Refinement Statistics
Unliganded NADP+
NADP+
Malic Acid
NADP+
W359F
NADP+
Q364H
Data collection
Space group P1 P1 P1 P1 P1
a, b, c (A˚) 61.47 63.75 71.55 61.65 63.76 71.74 61.44 63.71 71.82 61.50 63.69 71.92 61.40 63.61 71.85
a, b, g () 72.79 67.30 89.82 72.99 67.21 89.79 72.77 67.09 89.79 72.93 67.21 89.76 72.84 67.20 89.77
Resolution (A˚) 50–1.48 50–1.36 50–1.40 50–1.46 50–1.6
Rmerge 0.066 (0.478) 0.048 (0.264) 0.044 (0.450) 0.054(0.532) 0.105 (0.530)
I / s(I) 26.7 (2.0) 28.4.0 (3.7) 24.3 (2.0) 19.9 (1.9) 18.7 (2.2)
Completeness (%) 94.6 (92.2) 93.4 (90.6) 94.9 (91.7) 83.2 (91.9) 95.1 (93.0)
Redundancy 2.0 (2.0) 2.0 (1.9) 2.0 (2.0) 1.9 (2.0) 1.9 (1.9)
Refinement
Resolution (A˚) 50–1.48 50–1.36 50–1.40 50–1.46 50–1.60
Unique reflections 74,318 90,783 88,681 72,355 59,134
Rwork / Rfree 0.21/0.24 0.20/0.22 0.20/0.23 0.20/0.24 0.22/0.27
No. atoms
Protein 6813 6810 6916 6910 6918
NADP+ 96 96 96 96
Malic acid 36
Glycerol 6 6 12 12
Water 519 465 502 537 547
B-factors (A˚2)
Protein 22 15 17 18 19
NADP+ 20 13 17 16
Malic acid 42
Glycerol 24 24 35 27
Water 25 20 22 23 24
rmsd
Bond lengths (A˚) 0.031 0.033 0.031 0.027 0.027
Bond angles () 2.551 2.725 2.669 2.357 2.330
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Structure and Function of A-Type Ketoreductasesinto crystallization trials, and two different crystallization condi-
tions were identified. The structure was solved by molecular
replacement using TylKR1 (PDB Code: 2Z5L) as a search model
(Table 1). Crystals grown in the presence of 5 mM NADP+ show
clear electron density for NADP+. Interestingly, in the malic acid
crystallization condition, two malic acid molecules were
observed in the active site groove, one of which is bound to
the catalytic tyrosine and serine, adjacent to NADP+.
Ternary Complex Structure of AmpKR2, NADP+,
and Malic Acid
The overall structure of AmpKR2 consists of two subdomains,
each a variation of the Rossmann fold (Oppermann et al., 2003)
(Figure 2). The N-terminal 203 residues constitute the structural
subdomain, which lacks the traditional SDR cofactor binding
site and catalytic residues and apparently serves a structural
role stabilizing the catalytic subdomain. The catalytic residues
K330, S354, and Y367 in the C-terminal catalytic subdomain are
in the same orientation as observed in EryKR1 and TylKR1,
although AmpKR2 generates a b-hydroxyl group of opposite
stereochemistry, supporting the hypothesis that there are two
alternative binding modes for b-ketoacyl substrates in these
very similar active sites (Keatinge-Clay and Stroud, 2006;Structure 18, 91Keatinge-Clay, 2007). If the catalytic residues function as in
related SDR enzymes, S354 and Y367 of AmpKR2 hydrogen-
bond to the b-keto moiety of the natural triketide substrate
to position it adjacent to the reactive NADPH hydride, and the
positively charged amine of K330 facilitates Y367 in donating
a proton to the carbonyl oxygen following hydride transfer
(Oppermannetal., 2003). A loop,which in somemodulescontains
the ER domain, links the structural and catalytic subdomains via
17 residues. Loop DE, which contains the LDD motif in B-type
KRs, is 1 residue longer than the usual length (see Figure S1 avail-
able online) (Keatinge-Clay and Stroud, 2006). Structural align-
ments of AmpKR2 show higher structural homology to TylKR1
(1.54 A˚ Ca rmsd) than to EryKR1 (1.86 A˚ Ca rmsd). TylKR1 is one
of the rare B-type KRs that possess a tryptophan in the position
that identifies KRs as A-type. However, a structural comparison
of TylKR1 to AmpKR2 reveals that the tryptophan in TylKR1 is
positioned so the side chain NH is pointed toward the hydro-
phobic core, hydrogen-bonding a water molecule that is also
bound by T455, whereas the side chain NH of the AmpKR2
tryptophan is pointed toward the active site groove (Figure S1B).
TylKR1 was crystallized in the absence of NADPH, and while
EryKR1 was crystallized with NADPH, the nicotinamide half is
invisible in the electron density maps (Keatinge-Clay and Stroud,3–922, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 915
Figure 2. AmpKR2 Structure and Sequence Comparison with Other
KR Types
(A) Two monomers related through a twofold axis were observed in the P1 unit
cell andmay represent the dimeric organization of some KRs within intact PKS
modules. The structural subdomain is colored in red, and the catalytic subdo-
main is colored in green. The N termini, C termini, and lid helices are labeled,
and NADP+ and malic acid molecules are displayed in sticks.
(B) A sequence alignment compares key residues between different KR types;
the catalytic tyrosine and serine, the LDD motif of B-type KRs, the conserved
tryptophan of A-type KRs, and the conserved histidine residue of A2-type KR
are indicated by asterisks. See also Figure S1 and 4.
Figure 3. NADP+ Bound to AmpKR2
(A) jFoj – jFcj omit map of NADP+ superimposed on the final model (contoured
at 2.5 s).
(B) Ligplot diagram illustrating NADP+ interactions with AmpKR2 residues.
Structure
Structure and Function of A-Type Ketoreductases2006; Keatinge-Clay, 2007). The ternary complex structure of
AmpKR2 shows clearly defined electron density for the entire
NADP+ molecule bound to the catalytic subdomain (Figure 3).
The A face of NADP+ is positioned toward the catalytic tyrosine,
consistentwith the fact that the4-pro-Shydride isdelivered to the916 Structure 18, 913–922, August 11, 2010 ª2010 Elsevier Ltd All rib-ketoacyl substrate in all of the reduction reactions catalyzed by
EryKRs (McPhersonet al., 1998;Yin et al., 2001). Theadenine ring
forms hydrogen bonds with the D279 carboxylate and the A280
backbone NH, while the adenine ribose phosphate forms salt
bridges with R251 and R252. The nicotinamide ring is positioned
through hydrogen bonds with the W396 backbone amide and
a water molecule bound by the backbone carbonyls of W396
andV399. TheK330 side chain amine donates charged hydrogen
bonds to both the 20 and 30 hydroxyl groups of the nicotinamide
ribose, which in turn donate hydrogen bonds to the catalytic
Y367 phenolic oxygen and the backbone carbonyl of S305.
Charged hydrogen bonds are also formed between the NADP+
bridging phosphates and the backbone NH of I230, water mole-
cules bound to the N-terminal end of aB (the location of theghts reserved
Figure 4. The AmpKR2 Active Site
(A) A stereo diagram of NADP+ (yellow) and two
molecules of malic acid (cyan) bound in the cata-
lytic groove displays the 2Fo-Fc electron density
maps (contoured at 1.0 s).
(B) jFoj – jFcj omit maps of both molecules of malic
acid superimposed on the final model (contoured
at 2.5 s).
(C) Stereo diagram of diketide-SNAC modeled in
the active site.
Structure
Structure and Function of A-Type Ketoreductasesconserved GXGXXG dinucleotide binding motif), and the back-
bone NH of M401 located in the loop preceding the lid helix
(Figure 3B). That these residues are conserved in all reductase-
competent KR types lends support to the hypothesis thatNADPH
binds to all reductase-competent KRs in the same orientation.
In the ternary complex structure, two molecules of malic acid
are bound in the catalytic groove of AmpKR2 (Figure 4). One
molecule binds adjacent to the nicotinamide ring of NADP+ in
the region hypothesized to be where the polyketide substrate
binds. This molecule of malic acid makes contacts with several
active site residues, including the catalytic residues S354 and
Y367, lid helix residues V407 and L411, residue M401 from the
loop preceding the lid helix, as well as A309 and Q364. The other
molecule binds at the left end of the catalytic groove through
a hydrogen bond to a water molecule bound by W359 and
S361 as well as through hydrophobic contacts with L152,
S361, F449, and F453.
Effects of NADP+ and Malic Acid Binding
Structures of the unliganded AmpKR2 and the AmpKR2/NADP+
complex were obtained from crystals grown in an ammoniumStructure 18, 913–922, August 11, 2010sulfate crystallization condition. The
differences from the ternary structure
are slight, but informative (0.17 A˚ Ca
rmsd between unliganded AmpKR2 and
the AmpKR2/NADP+ complex; 0.21 A˚ Ca
rmsd between the unliganded AmpKR2
and ternary complex; and 0.13 A˚ Ca
rmsd between the AmpKR2/NADP+
complex and the ternary complex) (Fig-
ure 5). The lid helix is visible in the unli-
ganded structure although it possesses
elevated temperature factors. Part of
the loop (residues 399–404) precedingthe lid helix could not be modeled due to weak density. Intrigu-
ingly, the binding of NADP+ to AmpKR2 induced a more flexible
lid helix as the N terminus of the lid helix (residues 405–408)
became invisible in the density maps; however, residues
399–401, which are adjacent to the bound NADP+, became
more ordered compared with the unliganded structure. bB and
bC, which interact with the adenine are slightly longer than in
the unliganded structure, and the loop following bC achieves
a more well-ordered conformation. In the ternary complex with
NADP+ and malic acid, all residues are visible in the electron
density maps. M401 folds over the bound NADP+ and is both
more ordered and closer to the catalytic tyrosine compared
with the equivalent methionines in EryKR1 and TylKR1
(Figure S1B). The hydroxyl group of the S361 side chain, which
hydrogen bonds to Q364 in the unliganded structure, rotates
so that it can interact with a water molecule bound to malic
acid. Compared with the binary complex, NADP+ has reduced
B-factors. The most obvious conformational change in the
ternary complex is that the N-terminal end of the lid helix moves
4.6 A˚ away (comparing P405 Ca) from the active site compared
with the unliganded structure.Figure 5. Conformational Changes between
AmpKR2 Structures
Unliganded AmpKR2 (green), AmpKR2/NADP+
(cyan), and AmpKR2/NADP+/malic acid (purple)
structures are superposed. M401, Y367, S361,
malic acid, and NADP+ are displayed in sticks.
bB and bC are more extended in the liganded
structures. The N-terminal end of the lid helix is
4.6 A˚ farther from the catalytic tyrosine in the
ternary structure compared with the unliganded
structure.
ª2010 Elsevier Ltd All rights reserved 917
Figure 6. ACP Docking Model
The KR catalytic tyrosine, NADPH, and the ACP
serine that becomes phosphopantetheinylated
are highlighted in a top PatchDock docking
solution for AmpKR2 and AmpACP2.
Structure
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AmpKR2 catalyzes the reduction of a b-keto group to an
‘‘S’’-b–hydroxyl group while retaining the stereochemistry of
the unepimerized ‘‘R’’-a-methyl group, classifying it an A1-type
KR (Keatinge-Clay, 2007). The natural substrate of AmpKR2
is (2R, 4S, 5S)-5-hydroxyl-2,4-dimethyl-3-oxohexanoate holo-
AmpACP2 thioester. If AmpKR2 behaves analogous to the
A1-type EryKR2 with respect to (2RS)-methyl-3-oxopenta-
noate-SNAC, it would give a mixture of all four stereoisomeric
products (Siskos et al., 2005). Surprisingly, the (2R, 3S) product
was dominant, constituting 92.0% ± 1.1% of all products.
Attemptsweremade to obtain the ternary complexwith a nicotin-
amide cofactor and (2RS)-methyl-3-oxopentanoate-SNAC by
cocrystallization and soaking; however, only weak electron
density was observed for the diketide substrate. To elucidate
the details of the stereochemistry of epimer selection and ketor-
eduction, (2R)-methyl-3-oxopentanoate-SNAC was modeled
into the active site using the program Coot (Figure 4C). The
substrate was positioned over the nicotinamide ring of NADP+
so that the thioester carbonyl and b-keto group are nearly in
the same plane due to hydrogen bonds with S354 and Y367.
The conserved active site residue Q364 and lid helix residue
L411 are closest to the a-methyl group and a-hydrogen. The
A309, M401, and V407 side chains make contact with the
terminal portion of the diketide. The SNAC portion, whichmimics
the phosphopantetheinyl arm, is orientated at the left side of the
active site through hydrogen bonds to the side chains of S361
and the conserved A-type residue W359.
ACP Docking
An ACP must dock to the surface of a KR to present a phospho-
pantetheinyl-bound polyketide substrate to the KR active site.
To investigate possible protein-protein interactions, a model of
AmpACP2 was built with the structure of EryACP2 as a template
using the program ProtMod, and was subsequently docked onto
AmpKR2 using the program PatchDock (Alekseyev et al., 2007;
Schneidman-Duhovny et al., 2005). In several of the best
docking models, the AmpACP2 serine that becomes phospho-
pantetheinylated is located at the left end of the KR catalytic
groove, which would enable a polyketide substrate to approach918 Structure 18, 913–922, August 11, 2010 ª2010 Elsevier Ltd All rights reservedthe catalytic tyrosine from the left side. As
shown in one top-scoring dockingmodel,
the ACP helix II contacts the KR catalytic
groove while the ACP loop II contacts the
KR lid helix (Figure 6). The phosphopan-
tetheinylated serine of ACP is 16 A˚ from
the catalytic tyrosine and 6 A˚ from the
end of themodeled substrate that mimics
the phosphopantetheinyl arm. The valine
after the phosphopantetheinylated serine
(usually a hydrophobic residue) makeshydrophobic contact with L152, a conserved leucine at the C-
terminal end of a4 in the AmpKR2 structural subdomain that is
hypothesized to help form the ACP docking site in related
enzymes (Keatinge-Clay, 2007; Zhang et al., 2001). A salt bridge
is also formed between a conserved ACP helix II arginine and an
aspartate at the C-terminal end of a4.
Stereocontrol Assays
Chemical synthesis of a triketide substrate analog of the natural
substrate of AmpKR2 is made difficult by the spontaneous
cyclization of such compounds into triketide lactones. However,
a racemic mixture of the stable diketide substrate analog, (2RS)-
methyl-3-oxopentanoate-SNAC, was processed by AmpKR2 to
give 92.0% ± 1.1% of the anticipated (2R, 3S) stereoisomeric
product, as well as 3.0% ± 0.5% of the (2S, 3S) product and
5.0% ± 0.3% of the (2S, 3R) product (Figure 7). However,
when 3-oxopentanoate-SNAC, lacking the a-methyl substituent,
served as the substrate AmpKR2 gave more of the ‘‘3R’’ product
than the anticipated ‘‘3S’’ product (Figure 7D), revealing the
importance of the a-methyl group in orienting the substrate
at the active site for the reduction reaction. From the modeled
AmpKR2/NADPH/diketide ternary complex, several residues
were suspected to interact with polyketide substrates. To test
the importance of these residues, mutants were purified and
incubated with diketide-SNACs (Figures 7B and 7C).
All A-type KRs possess a conserved tryptophan residue that
is hypothesized to interact with the phosphopantetheinyl arm
to guide the substrate into the active site from the left side of
the catalytic groove (Figure 2B). To test this hypothesis, the con-
served tryptophan was mutated to phenylalanine; this mutation
is clearly observed in the electron density maps of the W359F
mutant (Figure S2). Analysis of the products derived from the
substrate (2RS)-methyl-3-oxopentanoate-SNAC from this mu-
tant revealed the formation of 68.4% ± 2.1% of the (2R, 3S)
product, 26.6% ± 2.0% of the (2S, 3S) product, and 4.9% ±
0.2% of the (2S, 3R) product. That the W359F mutation did not
severely compromise stereocontrol of b-hydroxyl groups sug-
gested that other residues aid in determining the stereochemical
outcome of the reduction reaction. The semiconserved residue
S361 is also in position to interact with the phosphopantetheinyl
Figure 7. KR Stereocontrol Assays
(A) Each reductase-competent KR type reduces (2RS)-methyl-3-oxopenta-
noate-SNAC to yield a distinct stereoisomeric product.
(B) The products from incubations of AmpKR2 andmutants with (2RS)-methyl-
3-oxopentanoate-SNACwere analyzed by chiral chromatography. Unmutated
AmpKR2 primarily forms the (2R, 3S) product. The Q364H mutant functions
more like an A2-type KR, producing mostly the (2S, 3S) product. The L411I
mutation has no obvious effect on stereocontrol. The W359F and S361A
mutations increase the proportion of the (2S, 3S) product but do not increase
the production of 3R products. The M401A mutation almost completely
abolishes enzyme activity. See also Figures S2 and S3.
(C) AmpKR1 and the H352Q AmpKR1 mutant were incubated with
(2RS)-methyl-3-oxopentanoate-SNAC. Unmutated AmpKR1 only forms the
(2S, 3S) product; the H352Q mutation does not effect stereospecificity but
causes a dramatic decrease in activity.
(D) AmpKR2 reduces more 3-oxopentanoate-SNAC to the 3R product than to
the anticipated 3S product.
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residue to alanine has a negligible effect on AmpKR2 stereocon-
trol. Curiously, the W359A/S361A double mutant only increases
the ‘‘R’’-b-hydroxy products to 9.6% ± 0.4% of the total prod-
ucts. However, each of these mutant enzymes did select more
of the 2S isomer for reduction compared with unmutated
AmpKR2.
Besides installing a b-hydroxyl group of ‘‘S’’ stereochemistry,
A2-type KRs also catalyze the epimerization of the a-substituent.
A highly conserved histidine has been identified 3 residues
before the catalytic tyrosine in A2-type KRs (Figure 2B). ToStructure 18, 91elucidate the role of the conserved histidine in A2-type KRs,
the corresponding Q364 in the A1-type AmpKR2 was mutated
to histidine (Figure S3). As expected, themajority of the products
from an incubation of the mutant with (2RS)-methyl-3-oxopenta-
noate-SNAC was the (2S, 3S) product (54.5% ± 1.1%). Interest-
ingly, the Q364Hmutant is more active than unmutated AmpKR2
(Figure 7B). Conversely, when the corresponding histidine in the
A2-type AmpKR1 was mutated to Q, no (2R, 3S) product was
produced; however, the activity of the mutant decreased to
6.0% ± 0.5% of the unmutated AmpKR1 (Figure 7C). The
AmpKR2 lid helix residue L411 is only 4 A˚ from the a-methyl
group and could potentially help select the unepimerized 2R
substrate for reduction (the corresponding residue is usually an
isoleucine in A2-type KRs). However, the L411I mutation was
shown not to alter AmpKR2 stereocontrol. In addition to folding
over the nicotinamide substrate, M401 may make contact with
the terminal portion of a diketide substrate. While the M401A
mutation did not affect stereocontrol, it almost completely
abolished the reductase activity of AmpKR2 (less than 2% of
the unmutated AmpKR2 activity).
KR Dimerization Element
Although there are remarkable similarities between the architec-
tures of type I PKSs and FASs, PKS modules often contain
subsets of the b-carbon processing enzymes that FASs possess
and must therefore be differently organized. According to the
mammalian FAS structure (Maier et al., 2006, 2008), only ERs
and DHs of the b-carbon processing enzymes contribute to the
dimerization interface of type I FASs. An 50 residue element
immediately precedes KRs in about half of PKS modules that
contain only KS, AT, KR, and ACP (Figure S4). In the AmpKR2
crystal structure, two AmpKR2 monomers in the P1 unit cell
are related through a twofold axis that is not imposed by the
crystal lattice (Figure 2A). The orientation of the two monomers
could represent the organization of AmpKR2 within the intact
amphotericin PKS. AmpKR2 migrates at 40 kDa compared
with molecular weight standards, consistent with the expected
monomer mass of 49 kDa; however, when the 50 residue
element is included on the AmpKR2 N terminus, the AmpKR2
migrates at 90 kDa, close to the anticipated dimer mass of
110 kDa, indicating that these residues serve as a dimerization
element (Figure S4B). Due to the presence of neighboring
b-carbon-processing domains, the KR catalytic tyrosines in the
mammalian FAS are separated by 116 A˚. If AmpKR2 dimerizes
in the orientation observed in the crystal structure, the distance
between equivalent catalytic tyrosines would be 53 A˚.
DISCUSSION
In modular PKSs, the stereochemistry of b-hydroxyl groups
is known to be determined by KRs; however, the detailed mech-
anisms of KR stereocontrol have not been fully elucidated.
Based on a correlation between sequencemotifs and the stereo-
chemistries of resulting b-hydroxyl groups, alternate substrate
binding orientations in different KR types have been proposed
(Caffrey, 2003; Reid et al., 2003). The LDD motif is hypothesized
to guide polyketides into the active sites of B-type KRs, while aW
motif is hypothesized to guide polyketides into the active sites of
A-type KRs; in this way, opposite faces of the polyketide b-keto3–922, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 919
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(Figures 2B and S1). Residues from the B-type LDD motif are
located on the right side of the catalytic groove, each in a position
to interact with the phosphopantetheinyl arm (Keatinge-Clay,
2007). The structure of AmpKR2 reveals the location and orien-
tation of the A-type tryptophan and an adjacent conserved
serine, both of which are in position to hydrogen-bond to the
phosphopantetheinyl arm to guide the polyketide into the active
site from the left side. Residues other than the LDD or W motif
must also contribute to stereocontrol; mutation of the second
aspartate in the LDD motif of EryKR1 to alanine did not compro-
mise stereocontrol, and the W359F/S361A AmpKR2 mutant
gave only 5% less of the expected A-type product (Keatinge-
Clay and Stroud, 2006). The chemical details of the polyketide
substrate can also greatly influence KR stereocontrol since
AmpKR2 functioned primarily as a B-type KR when incubated
with a diketide substrate lacking the a-methyl substituent (Fig-
ure 7D). Thus, in addition to the LDD and W motifs guiding the
phosphopantetheinyl arm, other residues in the catalytic groove
may need to complement the polyketide substrate.
Polyketide chain elongation catalyzed by KSs using 2S-meth-
ylmalonyl-CoA is accompanied by an inversion of a-methyl
configuration to give a polyketide with an R-a-methyl group
(Weissman et al., 1997). That subsequent epimerization occurs
during polyketide biosynthesis is readily demonstrated by the
numerous methyl groups in complex polyketides that possess
‘‘S’’ stereochemistry. KR domains have been determined to be
responsible for epimerization; however, the mechanistic details
are obscure (Valenzano et al., 2009). The EryKR1 structure
suggests that a conserved proline in B2-type KRs breaks the
helix to provide the catalytic tyrosine (in other KRs it lies within
the helix) the mobility to promote the abstraction of the acidic
a-hydrogen and catalyze tautomerization (Keatinge-Clay and
Stroud, 2006). The thioester and b-keto carbonyls, which nor-
mally electrostatically repulse one another, may be aligned
through hydrogen-bonding with the conserved tyrosine and
serine, promoting removal of the a-hydrogen due to its lowered
pKa in this orientation (Figure 4C). In methylmalonyl-coenzyme A
epimerase, the carboxylate and thioester carbonyl of themethyl-
malonyl group are positioned in same plane through the chela-
tion of a divalent ion (McCarthy et al., 2001). Once the polyketide
is enolized, it may return to the b-keto form through an uncata-
lyzed tautomerization, yielding the appropriate epimer for the
subsequent reduction reaction. Whether catalytic residues are
necessary to abstract the a-proton in epimerase-active KRs is
unclear; aside from the catalytic tyrosine and the A2-type histi-
dine, no residues that can serve as general acids or general
bases are conserved within these KRs. The A2-type histidine
may be in an appropriate position to hydrogen-bond with the
a-hydrogen of the epimerized polyketide. To test this hypothesis,
the conserved glutamine in AmpKR2 wasmutated to histidine by
site-directed mutagenesis and the resulting mutant was incu-
bated with (2RS)-methyl-3-oxopentanoate-SNAC. Incredibly,
the major product was that expected from an A2-type KR
(Figure 7B). However, since the substrates of the in vitro reac-
tions are racemic mixtures, in vivo experiments are necessary
to clarify whether this Q364H mutant can epimerize the 2R
epimer or whether it is more accepting of the 2S epimer. When
the A2-type AmpKR1 histidine was mutated to glutamine, the920 Structure 18, 913–922, August 11, 2010 ª2010 Elsevier Ltd All rienzyme lost 95% of its activity (Figure 7C), presumably because
it could no longer bind either the 2S epimer or the 2R epimer.
C2-type KRs such as EryKR3 and PikKR3 are reductase-inactive
due to their inability to bind NADPH but are hypothesized to be
epimerases (the catalytic tyrosine, serine, and lysine are still
conserved in these KRs) (Keatinge-Clay, 2007).
The binding of NADP+ and malic acid induces a significant
conformational change in AmpKR2 (Figure 5). Unliganded
AmpKR2 is in a relatively compact conformation. When NADP+
is bound, the lid helix becomes more flexible, and the acyl-
holo-ACP substrate has increased access to the catalytic
groove. When malic acid is added, the lid helix reorders to
produce a relatively open conformation surrounding the active
site (the N-terminal end of the lid helix shifts 4.6 A˚ away from
the active site compared with the unliganded structure). The
structure of unliganded TylKR1 shows a closed conformation;
however, both of the structures of EryKR1 complexed with
NADPH reveal open conformations (Figure S1). The closed
conformation represented by the TylKR1 structure was hypoth-
esized to be the active state during catalysis; however, the avail-
able KR structures may indicate that the open conformation
instead of the closed conformation is the active state during
catalysis (Keatinge-Clay, 2007). Induced fit is a well-known
model for the binding of substrates to enzymes (Koshland,
1958). KR residues move to interact with substrates and enable
catalysis, as illustrated by the crucial methionine that closes over
the nicotinamide cofactor and the ordering of the loop in which
the methionine resides. The conformation changes observed
for the lid helix indicate that the open state is the conformation
to which the ACP docks to deliver the phosphopantetheinyl-
bound polyketide substrate for reduction.
The first experiments on isolated KR domains indicated that
ACPs are not needed for stereocontrolled reduction reactions;
however, further investigation revealed the importance of ACPs
on KR stereocontrol (Siskos et al., 2005; Castonguay et al.,
2007). Remarkably, ACPs were also discovered to inhibit the
spontaneous epimerization of a-methyl groups (Castonguay
et al., 2007). A possible explanation of this phenomenon is that
the b-ketoacyl intermediates tethered to phosphopantetheinyl
arm bind in an ACP cleft, similar to the cleft observed in an
FAS ACP, so that the thioester and b-keto carbonyls are out of
plane (Roujeinikova et al., 2007; Castonguay et al., 2007). The
details of howACPs deliver substrates to their cognate KR active
sites are unclear. One hypothesis is that ACPs dock to different
KR types at the same location and that the phosphopantetheinyl
arm is oppositely guided by theW and LDDmotifs into the active
site. Another hypothesis is that ACPs dock to different KR types
such that the phosphopantetheinylated serine is positioned at
opposite sides of the catalytic tyrosine. The docking results for
the A1-type AmpKR2 does not rule out either hypothesis;
however, if the first hypothesis is correct, the phosphopante-
theinyl-bound polyketide would need to bend significantly in
B-type KRs to position the b-keto group appropriately for the
reduction reaction (Figure 6). The AmpKR2/AmpACP2 docking
model also suggests how b-ketoacyl intermediates slide into
the active site groove from the cleft between helix II and loop II
of ACP, shielded from bulk water. Similar protein-protein
interactions have been hypothesized between ACP and AT
(Wong et al., 2010).ghts reserved
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of complex polyketides are important targets in the engineering
of new compounds for drug development. While altered polyke-
tides have been produced through deletion and swapping of the
KRs that control these stereocenters, most often these large
structural alterations impair the function of engineered PKSs. A
more promising alternative may be to alter the residues in KRs
that confer stereocontrol, thereby maintaining the natural PKS
domain interactions. Thus, continued structural and functional
studies of KR stereocontrol may lead to the rational design of
polyketide stereocenters and new drug candidates.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The AmpKR2 domain was amplified from Streptomyces nodosus genomic
DNA using primers 50-ATCGTAATCCATATGGACGCCCTGCGCTACCACA
TCGA-30 (including the putative dimerization element), 50-ATCGTAATCCATA
TGGACTTCTGGCCCGAGCCGAAGAC-30 (excluding the putative dimeriza-
tion element), and 50-TGATTCGATGAATTCACTCGTCGCTGAGCGCCGAG
ACG-30, which produced NdeI-EcoRI sites (italics) for cloning into the same
sites of pET28b and allowed the incorporation of a stop codon (underlined)
at the 30 terminus of the DNA encoding AmpKR2. The resulting plasmids
were transformed into Escherichia coli BL21(DE3). The His-tagged protein
was overexpressed in LB media containing 50 mg/L kanamycin. Cultures
were grown at 37C to OD600 = 0.4 and induced with 0.5 mM IPTG for 12 hr
at 15C. The cells were then harvested by centrifugation at 5000 3 g for
20 min. The cell pellet was washed and resuspended with lysis buffer contain-
ing 500mMNaCl and 30mMHEPES (pH 7.5). The cell suspension was disrup-
ted by sonication and centrifuged at 30,000 3 g for 45 min to remove cell
debris. The cell-free extract was loaded onto Nickel-NTA resin (Qiagen) that
had been washed with lysis buffer. The column was washed with lysis buffer
containing 15 mM imidazole. His-tagged AmpKR2 was then eluted with lysis
buffer containing 300 mM imidazole. The elution was further polished using
a Superdex 200 gel filtration column equilibrated with 150 mM NaCl and
10 mM HEPES (pH7.5). Using protein concentrators, the resulting protein
was moved into a buffer containing 25 mM NaCl, 10 mM HEPES, and 1 mM
DTT (pH 7.5) at a concentration of 30 mg/ml.Crystallization and Structure Determination
For crystallization in the ammonium sulfate crystallization conditions, 20%
glycerol was added to the protein stock solution. Crystals were obtained in
two days by sitting-drop vapor diffusion at 21C with a 3.1 M ammonium
sulfate, 200 mM NaCl, 100 mM sodium cacodylate (pH 6.75) crystallization
condition using 2 ml protein solution: 2 ml crystallization solution. 5 mM
NADP+ was added to the protein solution to obtain crystals of the AmpKR2/
NADP+ complex. Crystals of AmpKR2 complexed with NADP+ and malic
acid were grown by mixing 2 ml of the protein solution containing 5% glycerol
and 5mMNADP+ with 0.6 ml 2.5 M DL-malic acid (pH 7.0). Data were collected
at Advanced Light Source Beamline 8.3.1 and processed with HKL2000 (Otwi-
nowski and Minor, 1997) (Table 1). The TylKR1 structure (PDB code 2Z5L) was
used as a search model for molecular replacement in Phaser (Keatinge-Clay,
2007; CCP4, 1994). The model was built in Coot (Emsley and Cowtan, 2004)
and refined through Refmac (CCP4, 1994). Figureswere prepared using PyMol
and LIGPLOT (DeLano, 2002; Wallace et al., 1995).Gel Filtration
Samples (0.1 ml) were injected onto a Superdex 200 gel filtration column
equilibrated with 150 mM NaCl and 10 mM HEPES (pH 7.5). The molecular
weight of a sample was determined through comparisons to known standards
(Gel Filtration Standard; Biorad Laboratories). Kav = (VeVo)/(VtVo), where Ve
is the volume at which the protein elutes (dextran blue 2000 and tyrosine were
used to determine Vo and Vt, respectively).Structure 18, 91KR Stereocontrol Assays
Reduction reactions were performed in a 200 ml solution containing 150 mM
NaCl, 50 mM NADP+, 10 mM glucose, 1 mM glucose dehydrogenase (from
Bacillus subtilis), 1 mM diketide-SNAC, 5 mM KR, 10% glycerol, and 50 mM
HEPES (pH 7.5). After incubation for 12 hr at 21C, reactions were extracted
with 800 ml ethyl acetate. After the evaporation of ethyl acetate, the extracts
were resuspended in 200 ml 93% hexanes and 7% ethanol. The reaction
products were separated and compared with known standards of the four
diastereoisomeric diketide products using a ChiralCel OC-H column (250 3
4.6 mm) on an Beckman Coulter HPLC system at a flow rate of 0.8 ml/min
in an isocratic mobile phase of 93% hexanes: 7% ethanol at 21C for 1 hr
(Siskos et al., 2005).
Mutation of KRs
Generation of mutants was accomplished using the GeneTailor Site-Directed
Mutagenesis System (Invitrogen) following the instructions of the manufac-
turer. The oligonucleotides used for mutagenesis were as follows: W359F,
50-TCCGGCGCCGCGGTCTTCGGCAGCGGTGGCCA-30 and 50- AGACCGC
GGCGCCGGACGAGAACAGCACG-30, Q364H, 50-TGGGGCAGCGGTGGCC
ATCCCGGCTACGCC-30 and 50- TGGCCACCGCTGCCCCAGACCGCGGCG
CC-30, S361A, 50-GTAGCCGGGCTGGCCACCGGCGCCCCAGACCGC-30
and 50-CGGTGGCCAGCCCGGCTACGCCGCCGCCAAC-30, L411I, 50-CCCC
GAGGTCCACGACCGGATCGTCCGCCAGGGCGT-30 and 50-CCGGTCGTGG
ACCTCGGGGTCGGTCGCCATGCCGA-30, M401A, 50-ACCTGGGGCGAGGT
CGGCGCGGCGACCGACCCCGA-30 and 50-GCCGACCTCGCCCCAGGTGC
CCCAGGCCACCGA-30, and Q352H 50-GGGGCAGCGGCGTGCAGGCCGCG
TATGTCG-30, and 50-TGCACGCCGCTGCCCCACATGCCGGCGGT-30. All
mutants were verified by DNA sequencing and purified using the same
protocol as used in the purification of the unmutated protein.
Docking of AmpACP2 to AmpKR2
A homology model of AmpACP2 was built by ProtMod (http://ffas.burnham.
org/protmod-cgi/protModHome.pl) using the structure of EryACP2 as the
template (Alekseyev et al., 2007). Docking was performed by PatchDock
(Schneidman-Duhovny et al., 2005) and refined in PhirDock (Andrusier et al.,
2007; Mashiach et al., 2008). Considering the 18 A˚ phosphopantetheinyl
arm of ACP, the distance from the ACP serine that becomes modified to the
KR active tyrosine was set between 5 and 25 A˚.
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The atomic coordinates have been deposited in the Protein Data Bank
with accession codes 3MJC (unliganded), 3MJE (with NADP+), 3MJS (with
NADP+ and malic acid), 3MJV (W359F and NADP+), and 3MJT (Q364H and
NADP+).
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